201 related articles for article (PubMed ID: 27169270)
21. Inability of rat DPP4 to allow MERS-CoV infection revealed by using a VSV pseudotype bearing truncated MERS-CoV spike protein.
Fukuma A; Tani H; Taniguchi S; Shimojima M; Saijo M; Fukushi S
Arch Virol; 2015 Sep; 160(9):2293-300. PubMed ID: 26138557
[TBL] [Abstract][Full Text] [Related]
22. Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice.
Li K; Wohlford-Lenane CL; Channappanavar R; Park JE; Earnest JT; Bair TB; Bates AM; Brogden KA; Flaherty HA; Gallagher T; Meyerholz DK; Perlman S; McCray PB
Proc Natl Acad Sci U S A; 2017 Apr; 114(15):E3119-E3128. PubMed ID: 28348219
[TBL] [Abstract][Full Text] [Related]
23. [Small molecular agents against MERS-CoV infection].
Zeng XY; Lu L; Jiang SB; Liu SW
Yao Xue Xue Bao; 2015 Dec; 50(12):1520-6. PubMed ID: 27169271
[TBL] [Abstract][Full Text] [Related]
24. Polymorphisms in dipeptidyl peptidase 4 reduce host cell entry of Middle East respiratory syndrome coronavirus.
Kleine-Weber H; Schroeder S; Krüger N; Prokscha A; Naim HY; Müller MA; Drosten C; Pöhlmann S; Hoffmann M
Emerg Microbes Infect; 2020; 9(1):155-168. PubMed ID: 31964246
[TBL] [Abstract][Full Text] [Related]
25. Coronavirus S protein-induced fusion is blocked prior to hemifusion by Abl kinase inhibitors.
Sisk JM; Frieman MB; Machamer CE
J Gen Virol; 2018 May; 99(5):619-630. PubMed ID: 29557770
[TBL] [Abstract][Full Text] [Related]
26. Development of Small-Molecule MERS-CoV Inhibitors.
Liang R; Wang L; Zhang N; Deng X; Su M; Su Y; Hu L; He C; Ying T; Jiang S; Yu F
Viruses; 2018 Dec; 10(12):. PubMed ID: 30562987
[TBL] [Abstract][Full Text] [Related]
27. Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors.
Wang C; Xia S; Zhang P; Zhang T; Wang W; Tian Y; Meng G; Jiang S; Liu K
J Med Chem; 2018 Mar; 61(5):2018-2026. PubMed ID: 29442512
[TBL] [Abstract][Full Text] [Related]
28. Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Infection, Immunological Response, and Vaccine Development.
Mubarak A; Alturaiki W; Hemida MG
J Immunol Res; 2019; 2019():6491738. PubMed ID: 31089478
[TBL] [Abstract][Full Text] [Related]
29. Middle East Respiratory Syndrome Coronavirus Spike Protein Is Not Activated Directly by Cellular Furin during Viral Entry into Target Cells.
Matsuyama S; Shirato K; Kawase M; Terada Y; Kawachi K; Fukushi S; Kamitani W
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021905
[TBL] [Abstract][Full Text] [Related]
30. Ca
Straus MR; Tang T; Lai AL; Flegel A; Bidon M; Freed JH; Daniel S; Whittaker GR
J Virol; 2020 Jun; 94(13):. PubMed ID: 32295925
[TBL] [Abstract][Full Text] [Related]
31. Glycosylation of mouse DPP4 plays a role in inhibiting Middle East respiratory syndrome coronavirus infection.
Peck KM; Cockrell AS; Yount BL; Scobey T; Baric RS; Heise MT
J Virol; 2015 Apr; 89(8):4696-9. PubMed ID: 25653445
[TBL] [Abstract][Full Text] [Related]
32. Middle East respiratory syndrome coronavirus infection is inhibited by griffithsin.
Millet JK; Séron K; Labitt RN; Danneels A; Palmer KE; Whittaker GR; Dubuisson J; Belouzard S
Antiviral Res; 2016 Sep; 133():1-8. PubMed ID: 27424494
[TBL] [Abstract][Full Text] [Related]
33. Advances in MERS-CoV Vaccines and Therapeutics Based on the Receptor-Binding Domain.
Zhou Y; Yang Y; Huang J; Jiang S; Du L
Viruses; 2019 Jan; 11(1):. PubMed ID: 30646569
[TBL] [Abstract][Full Text] [Related]
34. Adaptive Evolution of MERS-CoV to Species Variation in DPP4.
Letko M; Miazgowicz K; McMinn R; Seifert SN; Sola I; Enjuanes L; Carmody A; van Doremalen N; Munster V
Cell Rep; 2018 Aug; 24(7):1730-1737. PubMed ID: 30110630
[TBL] [Abstract][Full Text] [Related]
35. Mapping the Specific Amino Acid Residues That Make Hamster DPP4 Functional as a Receptor for Middle East Respiratory Syndrome Coronavirus.
van Doremalen N; Miazgowicz KL; Munster VJ
J Virol; 2016 Jun; 90(11):5499-5502. PubMed ID: 27030263
[TBL] [Abstract][Full Text] [Related]
36. Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion.
Coleman CM; Sisk JM; Mingo RM; Nelson EA; White JM; Frieman MB
J Virol; 2016 Oct; 90(19):8924-33. PubMed ID: 27466418
[TBL] [Abstract][Full Text] [Related]
37. Middle East respiratory syndrome coronavirus: transmission, virology and therapeutic targeting to aid in outbreak control.
Durai P; Batool M; Shah M; Choi S
Exp Mol Med; 2015 Aug; 47(8):e181. PubMed ID: 26315600
[TBL] [Abstract][Full Text] [Related]
38. HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV.
Milewska A; Chi Y; Szczepanski A; Barreto-Duran E; Dabrowska A; Botwina P; Obloza M; Liu K; Liu D; Guo X; Ge Y; Li J; Cui L; Ochman M; Urlik M; Rodziewicz-Motowidlo S; Zhu F; Szczubialka K; Nowakowska M; Pyrc K
J Virol; 2021 Jan; 95(4):. PubMed ID: 33219167
[TBL] [Abstract][Full Text] [Related]
39. Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus.
Zhou J; Li C; Zhao G; Chu H; Wang D; Yan HH; Poon VK; Wen L; Wong BH; Zhao X; Chiu MC; Yang D; Wang Y; Au-Yeung RKH; Chan IH; Sun S; Chan JF; To KK; Memish ZA; Corman VM; Drosten C; Hung IF; Zhou Y; Leung SY; Yuen KY
Sci Adv; 2017 Nov; 3(11):eaao4966. PubMed ID: 29152574
[TBL] [Abstract][Full Text] [Related]
40. Coronavirus Host Range Expansion and Middle East Respiratory Syndrome Coronavirus Emergence: Biochemical Mechanisms and Evolutionary Perspectives.
Peck KM; Burch CL; Heise MT; Baric RS
Annu Rev Virol; 2015 Nov; 2(1):95-117. PubMed ID: 26958908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
